Molecular diagnostic assay for detection of SARS-CoV-2. FDA-cleared in vitro diagnostic test providing reliable identification of COVID-19 infection.
Manufactured by
United States
Applied BioCode is a leading IVD manufacturer driving advances in multiplex molecular diagnostics for clinical and reference laboratories. Its proprietary Barcoded Magnetic Beads (BMB) technology combines digital barcoding with molecular chemistry to deliver high-throughput, highly accurate detection of multiplex panel targets on a single platform. Applied BioCode delivers flexible, high-throughput solutions on the BioCode MDx-3000 system, featuring FDA-cleared 17-plex respiratory and gastrointestinal panels, SARS-CoV-2 Flu plus RSV combination assays, and RUO panels targeting fungal pathogens and sexually transmitted infections with antimicrobial resistance markers. These solutions help laboratories streamline workflows, expand testing menus, and maximize efficiency.
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
Deaou Gene Technology Co.,Ltd
China · 1 relevant product
KogeneBiotech Co., Ltd.
South Korea · 3 relevant products
Credo Diagnostics Biomedical Pte. Ltd.
Singapore · 1 relevant product
88 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →17 more sourcing countries available
Get free access to all sourcing countries identified for this product.
See all countries →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
3 of 114 closest product alternatives
Deaou Gene Technology Co.,Ltd · China
Molecular diagnostic assay for SARS-CoV-2 detection with high sensitivity and specificity. Delivers reliable results for COVID-19 diagnosis in clinical and point-of-care settings.
KogeneBiotech Co., Ltd. · South Korea
Real-time PCR molecular diagnostic test for detection of SARS-CoV-2 virus. This assay enables rapid identification of COVID-19 infection through quantitative PCR methodology. The test was among the first developed and supplied in Korea.
Credo Diagnostics Biomedical Pte. Ltd. · Singapore
A rapid diagnostic test for detecting SARS-CoV-2 and future variants at the point of care. Plays a crucial role in infection control and prevention of viral spread.
111 more product alternatives available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products